AGIOS PHARMACEUTICALS, INC. Accrued Income Taxes, Current
AGIOS PHARMACEUTICALS, INC. (AGIO) had Accrued Income Taxes, Current of $1.46 million as of 2013-12-31, per its 10-Q filed 2014-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2014-05-09
- 2013-12-31: Accrued Income Taxes, Current $1.46M.
- 2013-09-30: Accrued Income Taxes, Current $5.26M.
- 2013-06-30: Accrued Income Taxes, Current $5.14M.
- 2012-12-31: Accrued Income Taxes, Current $4.88M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2013-12-31 | $1.46M 10-Q · filed 2014-05-09 |
| 2013-09-30 | $5.26M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $5.14M 10-Q · filed 2013-09-05 |
| 2012-12-31 | $4.88M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |